Figure 1From: Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain Decision analytic model. AE, adverse event; BMT, bone marrow transplant; HSCT, haematopoietic stem-cell transplant; IA, invasive aspergillosis.Back to article page